Clinical trial
A Randomised, Double-blind, Placebo Controlled, Multicentre Prospective Dose-finding Phase II/III Study With Atacicept Given Subcutaneously to Subjects Having Recently Experienced a Flare of Systemic Lupus Erythematosus (SLE)
NCT00624338 is registered in ClinicalTrials.gov with EMD Serono as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double-blind, Placebo Controlled, Multicentre Prospective Dose-finding Phase II/III Study With Atacicept Given Subcutaneously to Subjects Having Recently Experienced a Flare of Systemic Lupus Erythematosus (SLE)
- Lead sponsor
- EMD Serono
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- October 31, 2012
- Enrollment
- 461 (actual)
- Sites
- 113
Conditions
As the registry lists them; a condition with its own page is linked.